Call Us Today for a FREE CONSULTATION 205-933-1500
Dec 15 2011

Pfizer’s Zoloft, Taken For Depression, May Cause Birth Defects in Pregnant Women

Posted in Community Service, Product Liability

Zoloft a highly effective drug used in the medical treatment of depression, may cause birth defects in pregnant women, says Alabama liability attorney Keith T. Belt

The parents of a boy, who died shortly after he was born, allege he suffered Zoloft birth defects, which caused his death. Susan and James Hodge, of Akron, Ohio are alleging Pfizer knew or should have known about the risks associated with the use of Zoloft while pregnant. Their son, Dillion, was reportedly born with a birth defect called anencephaly, in which the infant is missing significant parts of the brain and skull. Dillion died 18 hours after he was born on October 1, 2009.

According to Susan Hodge, she read the Zoloft prescribing information before taking the drug and because there appeared to be no inclusion or emphasis on birth defects, believed that the drug was safe for her to use while pregnant. The lawsuit alleges that Pfizer should have warned the public and the medical community about the link between the use of Zoloft while pregnant and the risk of congenital birth defects but failed to adequately do so.

Anencephaly is a neural tube birth defect that occurs when the neural tube does not properly close during the developmental stages, usually during the third or fourth week of pregnancy. This results in the infant lacking a forebrain and cerebrum. Most infants die within a few hours or days of birth, often blind, deaf and unable to feel pain.

Zoloft is in a class of antidepressants called Selective Serotonin Reuptake Inhibitors (SSRIs). In a 2007 study published in the New England Journal of Medicine, researchers found a link between use of SSRI medications while pregnant and a risk of anencephaly. “We observed associations between SSRI use and the occurrence of anencephaly, craniosynostosis, and omphalocele, defects that had not been previously associated with maternal SSRI use in pregnancy,” researchers wrote. Specifically, they found that sertraline (the generic form of Zoloft) was associated with an increased risk of anencephaly.

Women who are pregnant or planning on becoming pregnant and are currently taking an antidepressant should not discontinue medication without speaking to a medical professional. Although studies suggest risks associated with the use of SSRI antidepressants while pregnant, there are also risks to having untreated depression while pregnant.